KLK3 and neoplasm: The actual application of the GIA test to therapy-monitoring needs to be validated in our subsequent validation study, in which a correlation will be made between results obtained from the GIA test with an accepted surrogate for therapy-effectiveness, such as PSA decline or radiographic tumour regression.